CAS 2407782-01-6

LDC7559

CAS : 2407782-01-6

LDC7559

Degré de pureté : ≥98%

Masse moléculaire : 349.38g/mol

Ref: 54-BUP05490

LDC7559

CAS : 2407782-01-6

LDC7559 is a reactive oxygen species-dependent compound that has been found to be cytotoxic against cancer cells. It induces cell lysis by oxidative damage, causing the release of cytoplasmic contents into the extracellular space. This compound also inhibits the production of inflammatory compounds such as prostaglandins, leukotrienes, and cytokines. LDC7559 is currently in phase II clinical trials for treating inflammatory bowel disease and experimental colitis. LDC7559 has also shown anti-inflammatory properties in vitro and in vivo models of autoimmune diseases such as asthma, arthritis, psoriasis, and Crohn's disease.

Formule : C₂₀H₁₉N₃O₃

Degré de pureté : Min. 95%

Masse moléculaire : 349.4 g/mol

Ref: 3D-HWD78201

LDC7559

CAS : 2407782-01-6

LDC7559 inhibits gasdermin D (GSDMD) by blocking neutrophil extracellular trap (NET) at late stage.

Formule : C₂₀H₁₉N₃O₃

Degré de pureté : 99.67% - 99.8%

Couleur et forme : Soild

Masse moléculaire : 349.38

Ref: TM-T11828